Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online November 15, 2022.
Article Versions
- Latest version (August 15, 2022 - 04:00).
- You are currently viewing a Latest version of this article (November 15, 2022 - 04:00).
- View the most recent version of this article
Copyright & Usage
© 2022 The Journal of Rheumatology
Author Information
- Ana-Maria Orbai,
- William Tillett,
- Suzanne Grieb,
- Steve Peterson,
- Elizabeth Holdsworth,
- Nicola Booth,
- Soumya D. Chakravarty and
- Laure Gossec
- The analysis described here using data from the Adelphi PsA IV Disease Specific Programme was funded by Janssen.
A.M. Orbai, MD, MHS, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; W. Tillett, PhD, Royal National Hospital for Rheumatic Disease, and University of Bath, Pharmacy and Pharmacology and Centre for Therapeutic Innovation, Bath, UK; S. Grieb, PhD, Patient Research Partner, Baltimore, Maryland, USA; S. Peterson, MSc, Janssen Global Services, Horsham, Pennsylvania, USA; E.A. Holdsworth, MSc, N. Booth, MSc, Adelphi Real World, Bollington, UK; S.D. Chakravarty, MD, Janssen Scientific Affairs, Horsham, and Drexel University College of Medicine, Philadelphia, Pennsylvania, USA; L. Gossec, MD, PhD, Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, and Pitié-Salpêtrière Hospital, AP-HP, Sorbonne Université, Rheumatology Department, Paris, France.
AMO has received research grants to Johns Hopkins University from AbbVie, Amgen, Celgene, Horizon, Janssen, Eli Lilly, Novartis, and Pfizer; and consulting fees from BMS, Janssen, Eli Lilly, Novartis, Pfizer, and UCB. WT has received research grants from AbbVie, Celgene, Janssen, GSK, and Eli Lilly; and consulting fees from AbbVie, Amgen, Celgene, Janssen, Eli Lilly, MSD, Novartis, Pfizer, GSK, and UCB. SG is engaged in the research or services as a private consultant and not in their capacity as a Johns Hopkins faculty member. NB and EAH are employees of Adelphi Real World. SP and SDC are employees of Janssen. LG has received research grants from Amgen, Galapagos, Janssen, Eli Lilly, Pfizer, Sandoz, and Sanofi; and consulting fees from AbbVie, Amgen, BMS, Biogen, Celgene, Gilead, Janssen, Eli Lilly, Novartis, Pfizer, Samsung Bioepis, Sanofi-Aventis, and UCB.
Address correspondence to Dr. A.M. Orbai, Johns Hopkins University School of Medicine, Division of Rheumatology, 5200 Eastern Avenue, Baltimore, MD 21224, USA. Email: aorbai1@jhmi.edu.
Accepted for publication July 26, 2022.